Today: 8 May 2026
Diageo shares sink after dividend cut and outlook trim as new CEO resets guidance
25 February 2026
2 mins read

Diageo shares sink after dividend cut and outlook trim as new CEO resets guidance

London, Feb 25, 2026, 10:15 GMT — Regular session

  • Diageo shares dropped roughly 6% at the open in London, as the company trimmed its dividend and revised down its full-year forecast.
  • The spirits maker pointed to sluggish U.S. demand—tequila especially lagging—and persistent headwinds in China.
  • Investors want to see if the cash and debt plan is delivering, and are eyeing a strategy update expected later this year.

Shares in Diageo slid roughly 6% Wednesday, with the Guinness and Johnnie Walker parent slashing its dividend and dialing down its full-year outlook—both moves arriving in the first set of results under new CEO Dave Lewis.

Diageo’s status as a heavyweight income stock in Britain makes this move significant, as a dividend reset often shifts its shareholder base. For CEO Lewis, the timing is notable too—it’s early days, and investors want proof his turnaround plan goes beyond just talk.

The read-through spread. Some European spirits stocks slipped, with traders debating if Diageo’s U.S. slowdown signals trouble for the whole premium liquor space, or if it’s just a Diageo issue.

Diageo posted a 4% drop in reported net sales for the first half, coming in at $10.46 billion. On an organic basis, which excludes the impact of currency movements and acquisitions, net sales were down 2.8%. The company also slashed its interim dividend to 20 cents a share, compared to 40.5 cents the previous year, and introduced a new annual dividend floor of 50 cents, targeting a payout ratio between 30% and 50%. CEO Lewis pointed to weaker U.S. spirits demand, citing “a more stretched consumer wallet”. www.diageo.com

Diageo has cut its fiscal 2026 outlook, now projecting a 2%-3% drop in organic sales and operating profit that lands flat or just slightly higher. The company cited a negative “price/mix”—the combined impact from pricing shifts and changing customer purchases—largely pointing to the U.S. and China as drivers.

North America dragged results lower. Diageo reported a 9.3% drop in U.S. sales for the half, with tequila plunging over 23%—a sharp turn for what had been a top growth driver.

Management flagged higher tariff costs and a more challenging trading backdrop, but said it managed to trim marketing outlays by finding what it described as efficiencies. A&P refers to advertising and promotion; the company emphasized it’s reallocating spend, not walking away from brands.

On the balance sheet, cash and debt drew attention. Diageo reported net debt of $21.7 billion as of Dec. 31, sticking to its $3 billion free cash flow target for the year. The company is also continuing with cost-savings efforts and asset sales.

Diageo pointed to expected proceeds from its agreement to offload its interests in East African Breweries and a Kenyan spirits operation to Asahi, with the transaction targeted for completion in the back half of calendar 2026. The company also noted that United Spirits’ review regarding Royal Challengers Bengaluru’s ownership had made significant progress.

Bulls face the possibility that the U.S. slowdown drags on, pressing companies into heavier discounting and trapping margins under the weight of product mix and tariffs. China remains unpredictable too. Diageo, for its part, continues grappling with what it described as persistent softness in Chinese white spirits.

Investors now turn to the interim dividend schedule, with ex-dividend dates for the UK and U.S. set for mid-April and the payment slated for June 4. Lewis is also due to lay out his strategy update before year-end.

Stock Market Today

  • Omnicell (OMCL) Stock Analysis: 71% Rebound Sparks Revaluation Debate
    May 8, 2026, 7:58 AM EDT. Omnicell's shares have surged about 70.7% over the past year, closing recently at $43.33. The stock showed mixed performance with a 4% year-to-date decline but strong recent gains. A Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by nearly 20%, estimating an intrinsic value of $53.90 per share. Omnicell's latest twelve-month free cash flow stands at $95.6 million, with growth projected through 2030. Despite the rebound, long-term performance includes significant declines over three and five years, mirroring challenges in the healthcare technology and automation sector. Investors are encouraged to weigh these fundamentals carefully, as Omnicell scores 2 out of 6 in undervaluation checks per Simply Wall St, signaling mixed signals for value assessment.

Latest article

Tempus AI Just Priced a $400 Million Debt Deal. Here’s What Investors Need to Watch

Tempus AI Just Priced a $400 Million Debt Deal. Here’s What Investors Need to Watch

8 May 2026
Tempus AI priced a $400 million private sale of 0% convertible senior notes due 2032, upsized from $350 million, to repay $307.7 million in loans and fund operations. The deal follows first-quarter revenue of $348.1 million, up 36%, but a net loss widened to $125.9 million. Shares traded at $49.47 premarket, down $4.07. The notes convert at $69.26 per share, a 40% premium to the last close.
Iron Mountain Incorporated Stock Falls After Six-Day Rally as AI Data-Center Bet Faces New Test

Iron Mountain Incorporated Stock Falls After Six-Day Rally as AI Data-Center Bet Faces New Test

8 May 2026
Cohere agreed in April to acquire Germany’s Aleph Alpha, aiming to expand in regulated European markets as governments demand “sovereign AI.” Schwarz Group plans to invest $600 million in Cohere, which was valued at $6.8 billion last year. The merged company will be based in Germany and Canada, targeting sectors like finance and defence. The deal awaits shareholder and regulatory approval.
Zoetis Stock Plunge: The Pet-Care Slowdown Wall Street Can’t Ignore

Zoetis Stock Plunge: The Pet-Care Slowdown Wall Street Can’t Ignore

8 May 2026
Zoetis cut its 2026 revenue forecast to $9.68 billion-$9.96 billion and lowered adjusted EPS guidance after U.S. companion-animal product sales dropped 11% in the first quarter. Shares fell $23.86 to $87.31. First-quarter adjusted EPS came in at $1.53, missing analyst estimates of $1.61. CEO Kristin Peck cited weaker demand, fewer vet visits, and increased competition.
Tokyo stock market today: Nikkei hits new record as yen weakens and AI jitters ease
Previous Story

Tokyo stock market today: Nikkei hits new record as yen weakens and AI jitters ease

MercadoLibre stock set for a rough open after profit miss and margin squeeze hits MELI
Next Story

MercadoLibre stock set for a rough open after profit miss and margin squeeze hits MELI

Go toTop